Marshall Wace’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$241K Buy
+22,782
New +$241K ﹤0.01% 2259
2025
Q1
Sell
-10,426
Closed -$172K 2457
2024
Q4
$172K Sell
10,426
-5,955
-36% -$98K ﹤0.01% 2217
2024
Q3
$405K Sell
16,381
-11,433
-41% -$282K ﹤0.01% 1851
2024
Q2
$705K Sell
27,814
-6,478
-19% -$164K ﹤0.01% 1651
2024
Q1
$871K Buy
34,292
+13,720
+67% +$348K ﹤0.01% 1492
2023
Q4
$466K Buy
+20,572
New +$466K ﹤0.01% 1454
2023
Q1
Sell
-15,845
Closed -$469K 2105
2022
Q4
$469K Buy
+15,845
New +$469K ﹤0.01% 1838
2022
Q3
Sell
-46,343
Closed -$1.03M 2525
2022
Q2
$1.03M Buy
+46,343
New +$1.03M ﹤0.01% 1860
2021
Q4
Sell
-9,536
Closed -$406K 3127
2021
Q3
$406K Buy
+9,536
New +$406K ﹤0.01% 1941
2021
Q2
Sell
-13,383
Closed -$546K 2076
2021
Q1
$546K Buy
+13,383
New +$546K ﹤0.01% 1611
2020
Q2
Sell
-6,177
Closed -$179K 1487
2020
Q1
$179K Buy
+6,177
New +$179K ﹤0.01% 1189
2019
Q3
Sell
-21,040
Closed -$855K 1609
2019
Q2
$855K Sell
21,040
-34,970
-62% -$1.42M 0.01% 945
2019
Q1
$1.69M Sell
56,010
-78,323
-58% -$2.37M 0.02% 786
2018
Q4
$4.52M Buy
+134,333
New +$4.52M 0.05% 472
2016
Q2
Sell
-19,081
Closed -$853K 965
2016
Q1
$853K Buy
19,081
+3,940
+26% +$176K 0.01% 750
2015
Q4
$578K Buy
+15,141
New +$578K 0.01% 785
2015
Q3
Sell
-9,413
Closed -$311K 901
2015
Q2
$311K Buy
+9,413
New +$311K ﹤0.01% 769
2015
Q1
Sell
-48,281
Closed -$1.97M 788
2014
Q4
$1.97M Sell
48,281
-24,852
-34% -$1.01M 0.03% 463
2014
Q3
$2.68M Buy
+73,133
New +$2.68M 0.04% 392